Jvalini T. Dwarkasing
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Correction: Enhanced Risk Stratification for Sentinel Lymph Node Biopsy in Head and Neck Melanoma Using the Merlin Assay (CP-GEP).
Journal: Annals of surgical oncology
Published: July 12, 2025
Flawed Benchmarks and Biased Cohorts: Reassessing the Evidence for CP-GEP (Merlin) Versus 31-GEP (DecisionDx-Melanoma).
Journal: International journal of dermatology
Published: June 27, 2025
Risk stratification using the Merlin Assay (CP-GEP) in an independent cohort of 930 patients with clinical stage I/II melanoma who did not undergo sentinel lymph node biopsy.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 14, 2025
Correction: Enhanced Risk Stratification for Sentinel Lymph Node Biopsy in Head and Neck Melanoma Using the Merlin Assay (CP-GEP).
Journal: Annals of surgical oncology
Published: January 30, 2025
Enhanced Risk Stratification for Sentinel Lymph Node Biopsy in Head and Neck Melanoma Using the Merlin Assay (CP-GEP).
Journal: Annals of surgical oncology
Published: July 12, 2024
Identification of stage I/II melanoma patients at high risk for recurrence using a model combining clinicopathologic factors with gene expression profiling (CP-GEP).
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 31, 2022
Cost evaluation of the Merlin assay for predicting melanoma sentinel lymph node biopsy metastasis.
Journal: International journal of dermatology
Published: July 17, 2022
Validation of a clinicopathological and gene expression profile model to identify patients with cutaneous melanoma where sentinel lymph node biopsy is unnecessary.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: September 30, 2021
The letter responds to comment on Identification of stage I/IIA melanoma patients at high risk of disease relapse using a clinicopathologic and gene expression model.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 21, 2021
Using the Merlin assay for reducing sentinel lymph node biopsy complications in melanoma: a retrospective cohort study.
Journal: International journal of dermatology
Published: August 02, 2021
Effects of whole-body vibration training in a cachectic C26 mouse model.
Journal: Scientific reports
Published: March 25, 2021
Last Updated: 09/26/2026